Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeep Shrestha

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2019
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilegeKyle B Woodward, Hong Zhao, Pradeep Shrestha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic ImmunosuppressionLalit Batra, Pradeep Shrestha, Hong Zhao, et al.
Vaccine|March 18, 2022
Nepal measles outbreak response immunization during COVID-19: A risk-based intervention strategyAnindya Sekhar Bose, Pasang Rai, Binod Prasad Gupta, et al.
Nature Materials|June 6, 2018
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptanceDevon M Headen, Kyle B Woodward, María M Coronel, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2019
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilegeKyle B Woodward, Hong Zhao, Pradeep Shrestha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic ImmunosuppressionLalit Batra, Pradeep Shrestha, Hong Zhao, et al.
Vaccine|March 18, 2022
Nepal measles outbreak response immunization during COVID-19: A risk-based intervention strategyAnindya Sekhar Bose, Pasang Rai, Binod Prasad Gupta, et al.
Nature Materials|June 6, 2018
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptanceDevon M Headen, Kyle B Woodward, María M Coronel, et al.
Pageof 4